INTERVENTIONAL CARDIOLOGY: IMPLANTABLE PACEMAKER PRODUCTS | GLOBAL MARKETS

65 Pages | 31 Exhibits | 2019 Analysis | Forecasts Through 2023 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for implantable pacemaker products.

INTERVENTIONAL CARDIOLOGY MARKET HIGHLIGHTS

  • Total unit sales for implantable pacemaker products are steadily increasing due to a number of factors, including: the increasing prevalence of CVD and cardiac rhythm disorders, advances in CVD diagnostics, and demand for cardiac rhythm disorder therapies in emerging markets.
  • In 2017, dual-chamber pacemakers accounted for the majority of worldwide implantable pacemaker product sales. Dual-chamber pacemakers are projected to account for the majority of total product sales throughout the forecast period covered by this report (2017-23).
  • The global market for implantable pacemaker products is anticipated to increase at a CAGR of 5.1% during the forecast period, reaching approximately $5,324.2m in total product sales by 2023.
  • The US was the largest market based on total implantable pacemaker product sales in 2017. Sales of these products to the US accounted for approximately 35.6% of total product sales in 2017.
  • Implantable pacemaker insertion is the primary treatment for certain cardiac rhythm disorders, specifically bradyarrhythmia. If left untreated, severe forms of bradyarrhytmia can cause cardiac arrest and death. While external pacemakers may also be used to treat bradyarrhythmia, they are not a convenient lon-term solution.
TOPICS COVERED INCLUDE:
  • An overview of implantable pacemaker products, including: single-chamber, dual-chamber, and cardiac resynchronization therapy pacemakers (CRT-P, or biventricular pacemakers).
  • Selected statistics for cardiac rhythm disorders and heart failure for the major regions covered in this report (eg the US, five major EU markets, and Japan).
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by country/region.
  • Discussion of key drivers and limiters impacting the major product segments.
  • A review of emerging technologies which could impact sales of existing devices.


TABLE OF CONTENTS:
Executive Summary 

i. Cardiac rhythm disorders overview
ii. Global implantable pacemaker products market 
	a. Market drivers and limiters
	b. Device segment insights 
	c. Technology trends
	d. Market leaders
	e. Competitive strategies
	f. Emerging competition 
iii. Methodology

Exhibit ES-1: Implantable pacemaker products, global market forecast, 2017-23 
Exhibit ES-2: Global implantable pacemaker products market, share by country/region, 2017 
Exhibit ES-3: Drivers and limiters of growth - implantable pacemaker products

1. Cardiac Rhythm Disorders Overview
 
1.1 Sick sinus syndrome
1.2 Bradycardia 
1.3 Heart block
1.4 Tachycardia 
1.5 Atrial fibrillation 
1.6 Heart failure 
1.7 Diagnosis and treatment
1.8 Bibliography 

Exhibit 1-1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias, based on health care utilization, select countries
Exhibit 1-2: Estimated number of hospital discharges for conduction disorders and cardiac arrhythmias, select countries
Exhibit 1-3: Estimated prevalence of atrial fibrillation, select countries, 2018
Exhibit 1-4: Estimated prevalence of chronic heart failure, select countries, 2018
Exhibit 1-5: Estimated prevalence of acute decompensated heart failure, select countries, 2018. 

2. Pacemaker Devices
 
2.1 Implantable pacemaker systems
	2.1.1 Implantable pacemaker products
	2.1.2 Developments in implantable pacemaker technology 
2.2 Temporary pacing systems 
	2.2.1 External pacemaker products
2.3 Bibliography 

Exhibit 2-1: NBG code for implantable pacemaker systems
Exhibit 2-2: Selected implantable pacemakers and manufacturers
Exhibit 2-3: EBR Systems' WiSE CRT system 
Exhibit 2-4: Selected external pacemakers and manufacturers

3. Implantable Pacemaker Products Market

3.1 Global market insights
	3.1.1 Market value
	3.1.2 Technology trends 
	3.1.3 Market drivers and limiters
	3.1.4 Implantable pacemaker products overview 
	3.1.5 Market leaders
	3.1.6 Competitive strategies
	3.1.7 Emerging competition 
3.2 Global competitors 
3.3 Market forecast
	3.3.1 Market forecast: US 
	3.3.2 Market forecast: five major EU markets
	3.3.3 Market forecast: Japan 
	3.3.4 Market forecast: rest of the world 
3.4 Bibliography 

Exhibit 3-1: Implantable pacemaker products, global market forecast ($m), 2017-23
Exhibit 3-2: Implantable pacemaker products, global market forecast ($m) by product type, 2017-23 
Exhibit 3-3: Global implantable pacemaker product sales, share by product segment, 2017
Exhibit 3-4: Global implantable pacemaker products market, share by country/region, 2017 
Exhibit 3-5: Global implantable pacemaker product sales, combined market forecast ($m), by country/region, 2017-23
Exhibit 3-6: Drivers and limiters of market growth - implantable pacemaker products
Exhibit 3-7: Implantable pacemaker products, share by product type, 2017 and 2023 
Exhibit 3-8: Global implantable pacemaker products market, share by supplier, 2017 
Exhibit 3-9: US Implantable pacemakers, procedure volumes forecast (000s), 2017-23
Exhibit 3-10: US Implantable pacemaker product sales, market forecast ($m) by product type, 2017-23 
Exhibit 3-11: US implantable pacemaker products market, share by supplier, 2017 
Exhibit 3-12: 5EU Implantable pacemakers, procedure volumes forecast (000s), 2017-23 
Exhibit 3-13: 5EU Implantable pacemaker product sales, market forecast ($m) by product type, 2017-23
Exhibit 3-14: 5EU implantable pacemaker products market, share by supplier, 2017 
Exhibit 3-15: Japanese Implantable pacemakers, procedure volumes forecast (000s), 2017-23 
Exhibit 3-16: Japanese Implantable pacemaker product sales, market forecast ($m) by product type, 2017-23 
Exhibit 3-17: Japanese implantable pacemaker products market, share by supplier, 2017 
Exhibit 3-18: RoW Implantable pacemaker product sales, market forecast ($m) by product type, 2017-23 
Exhibit 3-19: RoW implantable pacemaker products market, share by supplier, 2017 

Appendix: Company Listing


COMPANIES COVERED:

  1. Abbott
  2. BIOTRONIK
  3. Boston Scientific
  4. Ceryx Medical
  5. EBR Systems
  6. Galix Biomedical Instrumentation
  7. Lepu Medical
  8. Medtronic
  9. MicroPort Scientific
  10. Oscor
  11. Shree Pacetronix
  12. Vitatron
Contact Us

Need help finding medtech research? Let us help you!